TherapeuticsMD Plans On Raising $125 Million To Fund Commercialization Activities, Research & Clinical Trials

By: via Benzinga
Shares of TherapeuticsMD Inc (NYSE: TXMD) plunged more than 7 percent after Tuesday's market close following the company's announcement ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.